EXEL

Exelixis (EXEL)

About Exelixis (EXEL)

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Details

Daily high

$37.67

Daily low

$36.56

Price at open

52 Week High

$40.02

52 Week Low

$20.14

Market cap

10.1B

Dividend yield

0.00%

Volume

Avg. volume

2.5M

P/E ratio

20.75

Exelixis News